European Non-Communicable Respiratory Disease Research, 2002-13: Bibliometric Study of Outputs and Funding

This study was conducted in order to map European research in chronic respiratory diseases (CRDs). It was intended to assist the European Commission and other research funders to identify gaps and overlaps in their portfolios, and to suggest ways in which they could improve the effectiveness of their support and increase the impact of the research on patient care and on the reduction of the incidence of the CRDs. Articles and reviews were identified in the Web of Science on research in six non-communicable respiratory diseases that were published in 2002–13 from 31 European countries. They represented only 0.8% of biomedical research output but these diseases accounted for 4.7% of the European disease burden, as measured by Disability-Adjusted Life Years (DALYs), so the sub-field is seriously under-researched. Europe is prominent in the sub-field and published 56% of the world total, with the UK the most productive and publishing more than France and Italy, the next two countries, combined. Asthma and Chronic Obstructive Pulmonary Disease (COPD) were the diseases with the most publications and the highest citation rates. They also received the most funding, with around two acknowledgments per paper (in 2009–13), whereas cystic fibrosis and emphysema averaged only one. Just over 37% of papers had no specific funding and depended on institutional support from universities and hospitals.

[1]  G. Donaldson,et al.  Tele-monitoring reduces exacerbation of COPD in the context of climate change–a randomized controlled trial , 2013, Environmental Health.

[2]  P. Farrell,et al.  The prevalence of cystic fibrosis in the European Union. , 2008, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[3]  D. Yach,et al.  The global burden of chronic diseases: overcoming impediments to prevention and control. , 2004, JAMA.

[4]  Z. Liao,et al.  Scientific publications in respiratory journals from Chinese authors in various parts of North Asia: a 10-year survey of literature , 2014, BMJ Open.

[5]  S. Hazout,et al.  Complete map of cystic fibrosis mutation DF508 frequencies in Western Europe and correlation between mutation frequencies and incidence of disease. , 1995, Human biology.

[6]  D. Ashby,et al.  Time to publication as full reports of abstracts of randomized controlled trials in cystic fibrosis , 1998, Pediatric pulmonology.

[7]  P. Kinney,et al.  Modeling of regional climate change effects on ground-level ozone and childhood asthma. , 2011, American journal of preventive medicine.

[8]  H. Jónsdóttir,et al.  Smoking addiction in chronic obstructive pulmonary disease , 2014, Chronic respiratory disease.

[9]  Thierry Troosters,et al.  COPD as a Lung Disease with Systemic Consequences – Clinical Impact, Mechanisms, and Potential for Early Intervention , 2008, COPD.

[10]  Grant Lewison,et al.  Conflicts of interest statements on biomedical papers , 2014, Scientometrics.

[11]  P. Shekelle,et al.  Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society , 2011, Annals of Internal Medicine.

[12]  L. Trupin,et al.  The occupational burden of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[13]  Cristian Scutaru,et al.  Scientometric Analysis and Combined Density-Equalizing Mapping of Environmental Tobacco Smoke (ETS) Research , 2010, PloS one.

[14]  P. Piirilä,et al.  Combined Effect of Smoking and Occupational Exposure to Dusts, Gases or Fumes on the Incidence of COPD , 2014, COPD.

[15]  M. Stanton,et al.  Cystic fibrosis mortality and survival in the UK: 1947–2003 , 2007, European Respiratory Journal.

[16]  F. Narin,et al.  The international distribution of biomedical publications. , 1977, Federation proceedings.

[17]  X. Busquets,et al.  Systemic effects of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[18]  L. Ziska,et al.  Rising CO2 and pollen production of common ragweed (Ambrosia artemisiifolia), a known allergy-inducing species: implications for public health. , 2000 .

[19]  D. Mannino,et al.  Changing the burden of COPD mortality , 2006, International journal of chronic obstructive pulmonary disease.

[20]  J. Kongerud,et al.  The incidence of work-related asthma-like symptoms and dust exposure in Norwegian smelters. , 2012, American journal of respiratory and critical care medicine.

[21]  A. Agustí,et al.  Systemic inflammation and comorbidities in chronic obstructive pulmonary disease. , 2012, Proceedings of the American Thoracic Society.

[22]  J. Neuberger,et al.  Cardiovascular effect of bans on smoking in public places. , 2008, The American journal of cardiology.

[23]  Grant Lewison,et al.  The evaluation of Russian cancer research , 2010 .

[24]  J. Palmer,et al.  Active and passive smoking and the incidence of asthma in the Black Women's Health Study. , 2015, American journal of respiratory and critical care medicine.

[25]  L. Ziska,et al.  Cities as harbingers of climate change: common ragweed, urbanization, and public health. , 2003, The Journal of allergy and clinical immunology.

[26]  H. Bambrick,et al.  Is the Global Rise of Asthma an Early Impact of Anthropogenic Climate Change? , 2005, Environmental health perspectives.

[27]  D. Fanti,et al.  Efficacy of a three day course of azithromycin in moderately severe community-acquired pneumonia. , 1995, The European respiratory journal.

[28]  J Bousquet,et al.  Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. , 2001, Bulletin of the World Health Organization.

[29]  Grant Lewison,et al.  Input indicators from output measures: a bibliometric approach to the estimation of malaria research funding , 2002 .

[30]  F. Río,et al.  Análisis y evolución de los indicadores bibliométricos de producción y consumo del área de tabaquismo a través de Archivos De Bronconeumología (período 1970–2000). Comparación con otras áreas neumológicas , 2002 .

[31]  J. Neuberger,et al.  Cardiovascular effect of bans on smoking in public places: a systematic review and meta-analysis. , 2009, Journal of the American College of Cardiology.

[32]  Petr Heneberg.  Lifting the fog of scientometric research artifacts: On the scientometric analysis of environmental tobacco smoke research , 2013, J. Assoc. Inf. Sci. Technol..

[33]  M. Neidell,et al.  Air pollution, health, and socio-economic status: the effect of outdoor air quality on childhood asthma. , 2004, Journal of health economics.

[34]  G Lewison,et al.  Research outputs in respiratory medicine , 2004, Thorax.

[35]  J Bousquet,et al.  Global Alliance against Chronic Respiratory Diseases , 2007, European Respiratory Journal.

[36]  S. Glantz,et al.  Declines in Acute Myocardial Infarction After Smoke-Free Laws and Individual Risk Attributable to Secondhand Smoke , 2009, Circulation.

[37]  J C Yernault,et al.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.

[38]  A. Agustí.  Systemic effects of chronic obstructive pulmonary disease. , 2001, Novartis Foundation symposium.